Skip to main content

Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.

Publication ,  Journal Article
Harding, CO; Gillingham, MB; Hamman, K; Clark, H; Goebel-Daghighi, E; Bird, A; Koeberl, DD
Published in: Gene Ther
March 2006

Novel recombinant adeno-associated virus vectors pseudotyped with serotype 8 capsid (rAAV2/8) have recently shown exciting promise as effective liver-directed gene transfer reagents. We have produced a novel liver-specific rAAV2/8 vector expressing the mouse phenylalanine hydroxylase (Pah) cDNA and have administered this vector to hyperphenylalaninemic PAH-deficient Pah(enu2) mice, a model of human phenylketonuria (PKU). Our hypothesis was that this vector would produce sufficient hepatocyte transduction frequency and PAH activity to correct blood phenylalanine levels in murine PKU. Portal vein injection of recombinant AAV2/8 vector into five adult Pah(enu2) mice yielded complete and stable (up to 17 weeks) correction of serum phenylalanine levels. Liver PAH activity was corrected to 11.5+/-2.4% of wild type liver activity and was associated with a significant increase in phenylalanine clearance following parenteral phenylalanine challenge. Although questions of long-term safety and stability of expression remain, recombinant AAV2/8-mediated, liver-directed gene therapy is a promising novel treatment approach for PKU and allied inborn errors of metabolism.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gene Ther

DOI

ISSN

0969-7128

Publication Date

March 2006

Volume

13

Issue

5

Start / End Page

457 / 462

Location

England

Related Subject Headings

  • Transduction, Genetic
  • Recombinant Proteins
  • Pigmentation Disorders
  • Phenylketonurias
  • Phenylalanine Hydroxylase
  • Models, Animal
  • Mice, Inbred C57BL
  • Mice
  • Liver
  • Hair Color
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harding, C. O., Gillingham, M. B., Hamman, K., Clark, H., Goebel-Daghighi, E., Bird, A., & Koeberl, D. D. (2006). Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria. Gene Ther, 13(5), 457–462. https://doi.org/10.1038/sj.gt.3302678
Harding, C. O., M. B. Gillingham, K. Hamman, H. Clark, E. Goebel-Daghighi, A. Bird, and D. D. Koeberl. “Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.Gene Ther 13, no. 5 (March 2006): 457–62. https://doi.org/10.1038/sj.gt.3302678.
Harding CO, Gillingham MB, Hamman K, Clark H, Goebel-Daghighi E, Bird A, et al. Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria. Gene Ther. 2006 Mar;13(5):457–62.
Harding, C. O., et al. “Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.Gene Ther, vol. 13, no. 5, Mar. 2006, pp. 457–62. Pubmed, doi:10.1038/sj.gt.3302678.
Harding CO, Gillingham MB, Hamman K, Clark H, Goebel-Daghighi E, Bird A, Koeberl DD. Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria. Gene Ther. 2006 Mar;13(5):457–462.

Published In

Gene Ther

DOI

ISSN

0969-7128

Publication Date

March 2006

Volume

13

Issue

5

Start / End Page

457 / 462

Location

England

Related Subject Headings

  • Transduction, Genetic
  • Recombinant Proteins
  • Pigmentation Disorders
  • Phenylketonurias
  • Phenylalanine Hydroxylase
  • Models, Animal
  • Mice, Inbred C57BL
  • Mice
  • Liver
  • Hair Color